{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:38:03Z","timestamp":1792546683114,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T00:00:00Z","timestamp":1492473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s11914-017-0359-y","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T02:55:22Z","timestamp":1492484122000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Parathyroid Diseases and T Cells"],"prefix":"10.1007","volume":"15","author":[{"given":"M.","family":"Neale Weitzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,18]]},"reference":[{"issue":"25","key":"359_CR1","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med. 2011;365(25):2389\u201397.","journal-title":"N Engl J Med"},{"issue":"3","key":"359_CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266\u201381.","journal-title":"N Engl J Med"},{"issue":"3","key":"359_CR3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bone.2010.04.611","volume":"47","author":"R Pacifici","year":"2010","unstructured":"Pacifici R. T cells: critical bone regulators in health and disease. Bone. 2010;47(3):461\u201371.","journal-title":"Bone"},{"issue":"3","key":"359_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1172\/JCI11296","volume":"107","author":"LM Calvi","year":"2001","unstructured":"Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, et al. Activated parathyroid hormone\/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest. 2001;107(3):277\u201386.","journal-title":"J Clin Invest"},{"issue":"8","key":"359_CR5","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1210\/en.2014-1046","volume":"155","author":"AN Ben-awadh","year":"2014","unstructured":"Ben-awadh AN, Delgado-Calle J, Tu X, Kuhlenschmidt K, Allen MR, Plotkin LI, et al. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes. Endocrinology. 2014;155(8):2797\u2013809.","journal-title":"Endocrinology"},{"key":"359_CR6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bone.2014.06.006","volume":"66","author":"J Xiong","year":"2014","unstructured":"Xiong J, Piemontese M, Thostenson JD, Weinstein RS, Manolagas SC, O'Brien CA. Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency. Bone. 2014;66:146\u201354.","journal-title":"Bone"},{"issue":"7","key":"359_CR7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi M. Skeletal remodeling in health and disease. Nat Med. 2007;13(7):791\u2013801.","journal-title":"Nat Med"},{"issue":"7","key":"359_CR8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrendo.2015.71","volume":"11","author":"IR Reid","year":"2015","unstructured":"Reid IR. Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol. 2015;11(7):418\u201328.","journal-title":"Nat Rev Endocrinol."},{"issue":"4","key":"359_CR9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jbmr.2394","volume":"30","author":"JW Robinson","year":"2015","unstructured":"Robinson JW, Li JY, Walker LD, Tyagi AM, Reott MA, Yu M, et al. T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment. J Bone Miner Res. 2015;30(4):695\u2013705.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"359_CR10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrendo.2016.91","volume":"12","author":"MN Weitzmann","year":"2016","unstructured":"Weitzmann MN, Ofotokun I. Physiological and pathophysiological bone turnover\u2014role of the immune system. Nat Rev Endocrinol. 2016;12(9):518\u201332.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"359_CR11","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","volume":"116","author":"MN Weitzmann","year":"2006","unstructured":"Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006;116(5):1186\u201394.","journal-title":"J Clin Invest"},{"issue":"9","key":"359_CR12","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","volume":"109","author":"Y Li","year":"2007","unstructured":"Li Y, Toraldo G, Li A, Yang X, Zhang H, Qian WP, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood. 2007;109(9):3839\u201348.","journal-title":"Blood"},{"issue":"11","key":"359_CR13","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.161.11.6113","volume":"161","author":"TJ Yun","year":"1998","unstructured":"Yun TJ, Chaudhary PM, Shu GL, Frazer JK, Ewings MK, Schwartz SM, et al. OPG\/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol. 1998;161(11):6113\u201321.","journal-title":"J Immunol"},{"issue":"31","key":"359_CR14","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.1073\/pnas.1003020107","volume":"107","author":"T Vikulina","year":"2010","unstructured":"Vikulina T, Fan X, Yamaguchi M, Roser-Page S, Zayzafoon M, Guidot DM, et al. Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proc Natl Acad Sci U S A. 2010;107(31):13848\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"359_CR15","volume":"10","author":"K Titanji","year":"2014","unstructured":"Titanji K, Vunnava A, Sheth AN, Delille C, Lennox JL, Sanford SE, et al. Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. PLoS Pathog. 2014;10(10):e1004497.","journal-title":"PLoS Pathog"},{"issue":"9","key":"359_CR16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S Kotake","year":"1999","unstructured":"Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103(9):1345\u201352.","journal-title":"J Clin Invest"},{"issue":"9","key":"359_CR17","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1002\/jcb.24165","volume":"113","author":"CJ DeSelm","year":"2012","unstructured":"DeSelm CJ, Takahata Y, Warren J, Chappel JC, Khan T, Li X, et al. IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner. J Cell Biochem. 2012;113(9):2895\u2013902.","journal-title":"J Cell Biochem"},{"issue":"8","key":"359_CR18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","volume":"111","author":"G Eghbali-Fatourechi","year":"2003","unstructured":"Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest. 2003;111(8):1221\u201330.","journal-title":"J Clin Invest"},{"issue":"10","key":"359_CR19","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","volume":"106","author":"S Cenci","year":"2000","unstructured":"Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest. 2000;106(10):1229\u201337.","journal-title":"J Clin Invest"},{"issue":"6759","key":"359_CR20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999;402(6759):304\u20139.","journal-title":"Nature"},{"issue":"5","key":"359_CR21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03343723","volume":"23","author":"BG Hory","year":"2000","unstructured":"\u2022 Hory BG, Roussanne MC, Rostand S, Bourdeau A, Drueke TB, Gogusev J. Absence of response to human parathyroid hormone in athymic mice grafted with human parathyroid adenoma, hyperplasia or parathyroid cells maintained in culture. J Endocrinol Investig. 2000;23(5):273\u20139. This was the first study to suggest a role for T cells in hyperparathyroid bone loss.","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"359_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1\u201319.","journal-title":"Osteoporos Int"},{"key":"359_CR23","doi-asserted-by":"crossref","unstructured":"Riggs BL, Melton 3rd. LJ. Involutional osteoporosis. N Engl J Med. 1986;314(26):1676\u201386.","DOI":"10.1056\/NEJM198606263142605"},{"issue":"8","key":"359_CR24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012290","volume":"5","author":"H Tawfeek","year":"2010","unstructured":"\u2022 Tawfeek H, Bedi B, Li JY, Adams J, Kobayashi T, Weitzmann MN, et al. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. PLoS One. 2010;5(8):e12290. This study demonstrated for the first time that direct PTH signaling in T cells is necessary for bone catabolism by conditional ablation of the T cell PPR.","journal-title":"PLoS One"},{"issue":"9","key":"359_CR25","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","volume":"142","author":"YL Ma","year":"2001","unstructured":"Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, et al. Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology. 2001;142(9):4047\u201354.","journal-title":"Endocrinology"},{"issue":"4","key":"359_CR26","first-page":"477","volume":"67","author":"TA Guise","year":"1992","unstructured":"Guise TA, Chirgwin JM, Favarato G, Boyce BF, Mundy GR. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice. Lab Investig. 1992;67(4):477\u201385.","journal-title":"Lab Investig"},{"issue":"2","key":"359_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2008.07.001","volume":"8","author":"Y Gao","year":"2008","unstructured":"\u2022 Gao Y, Wu X, Terauchi M, Li JY, Grassi F, Galley S, et al. T cells potentiate PTH-induced cortical bone loss through CD40L signaling. Cell Metab. 2008;8(2):132\u201345. This study showed that a T cell costimulatory ligand (CD40L) interacts with BMSC expressed CD40 receptor to prime BMSC to respond to cPTH.","journal-title":"Cell Metab"},{"issue":"12","key":"359_CR28","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000;106(12):1481\u20138.","journal-title":"J Clin Invest"},{"issue":"1","key":"359_CR29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1074\/jbc.M008198200","volume":"276","author":"YH Zhang","year":"2001","unstructured":"Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem. 2001;276(1):563\u20138.","journal-title":"J Biol Chem"},{"issue":"3","key":"359_CR30","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/endo.143.3.8701","volume":"143","author":"K Fuller","year":"2002","unstructured":"Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology. 2002;143(3):1108\u201318.","journal-title":"Endocrinology"},{"issue":"3","key":"359_CR31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","volume":"25","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone. 1999;25(3):255\u20139.","journal-title":"Bone"},{"issue":"12","key":"359_CR32","doi-asserted-by":"crossref","first-page":"8287","DOI":"10.4049\/jimmunol.175.12.8287","volume":"175","author":"N Young","year":"2005","unstructured":"Young N, Mikhalkevich N, Yan Y, Chen D, Zheng WP. Differential regulation of osteoblast activity by Th cell subsets mediated by parathyroid hormone and IFN-gamma. J Immunol. 2005;175(12):8287\u201395.","journal-title":"J Immunol"},{"issue":"1","key":"359_CR33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1210\/endo.130.1.1309334","volume":"130","author":"LK McCauley","year":"1992","unstructured":"McCauley LK, Rosol TJ, Merryman JI, Capen CC. Parathyroid hormone-related protein binding to human T-cell lymphotropic virus type I-infected lymphocytes. Endocrinology. 1992;130(1):300\u20136.","journal-title":"Endocrinology"},{"issue":"3","key":"359_CR34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cmet.2009.07.010","volume":"10","author":"M Terauchi","year":"2009","unstructured":"Terauchi M, Li JY, Bedi B, Baek KH, Tawfeek H, Galley S, et al. T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling. Cell Metab. 2009;10(3):229\u201340.","journal-title":"Cell Metab"},{"issue":"9","key":"359_CR35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009;361(9):888\u201398.","journal-title":"N Engl J Med"},{"issue":"1","key":"359_CR36","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","volume":"12","author":"IE Adamopoulos","year":"2010","unstructured":"Adamopoulos IE, Chao CC, Geissler R, Laface D, Blumenschein W, Iwakura Y, et al. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther. 2010;12(1):R29.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"359_CR37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2015.09.012","volume":"22","author":"JY Li","year":"2015","unstructured":"\u2022 Li JY, D'Amelio P, Robinson J, Walker LD, Vaccaro C, Luo T, et al. IL-17A is increased in humans with primary hyperparathyroidism and mediates PTH-induced bone loss in mice. Cell Metab. 2015;22(5):799\u2013810. This study demonstrates a role of Th17 and IL-17A in the osteoclastic bone resorption induced by cPTH.","journal-title":"Cell Metab"},{"issue":"12","key":"359_CR38","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"\u2022 Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203(12):2673\u201382. The first major study showing the key role of Th17 T cells and IL-17A to RANKL production and osteoclastic bone resorption in autoimmune arthritis.","journal-title":"J Exp Med"},{"issue":"9","key":"359_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044552","volume":"7","author":"AM Tyagi","year":"2012","unstructured":"Tyagi AM, Srivastava K, Mansoori MN, Trivedi R, Chattopadhyay N, Singh D. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One. 2012;7(9):e44552.","journal-title":"PLoS One"},{"issue":"4","key":"359_CR40","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1084\/jem.192.4.F9","volume":"192","author":"CD Surh","year":"2000","unstructured":"Surh CD, Sprent J. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J Exp Med. 2000;192(4):F9\u2013F14.","journal-title":"J Exp Med"},{"issue":"9","key":"359_CR41","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1517\/13543784.9.9.2147","volume":"9","author":"N Najafian","year":"2000","unstructured":"Najafian N, Sayegh MH. CTLA4-Ig: a novel immunosuppressive agent. Expert Opin Investig Drugs. 2000;9(9):2147\u201357.","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"359_CR42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1749-6632.2009.05216.x","volume":"1192","author":"B Bedi","year":"2010","unstructured":"\u2022 Bedi B, Li JY, Grassi F, Tawfeek H, Weitzmann MN, Pacifici R. Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss. Ann N Y Acad Sci. 2010;1192(1):215\u201321. This study shows that endogenous basal antigen presentation to T cells is necessary for iPTH to promote catabolic effects though T cells.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"359_CR43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1074-7613(00)80092-8","volume":"11","author":"B Ernst","year":"1999","unstructured":"Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity. 1999;11(2):173\u201381.","journal-title":"Immunity"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-017-0359-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T04:36:34Z","timestamp":1692765394000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-017-0359-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,18]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1007\/s11914-017-0359-y","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,18]]}}}